World's Best Scientists 2026 revealed!
Giampiero Girolomoni

Giampiero Girolomoni

D-Index & Metrics

Medicine

D-Index
112
Citations
44057
World Ranking
5157
National Ranking
160

Giampiero Girolomoni publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Giampiero Girolomoni sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 714 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Giampiero Girolomoni D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Giampiero Girolomoni sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 112 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Giampiero Girolomoni is affiliated with the University of Verona in Italy and has contributed extensively to the field of medical research, with a strong focus on dermatology and related disciplines. Their work is primarily situated within the field of Medicine, with particular attention to Dermatology, Immunology, Immunology and Allergy, Rheumatology, and Physiology.

The scientist's research covers a range of topics including:

  • Dermatology and Skin Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Allergic Rhinitis and Sensitization
  • Asthma and respiratory diseases
  • Autoimmune Bullous Skin Diseases
  • Urticaria and Related Conditions
  • Food Allergy and Anaphylaxis Research

Girolomoni has been published frequently in several academic journals. The main publication venues include:

  • Journal of the European Academy of Dermatology and Venereology
  • Italian Journal of Dermatology and Venereology
  • Journal of the American Academy of Dermatology
  • Vaccines
  • Dermatology and Therapy

Some of the recent papers associated with or related to Girolomoni's co-authors include:

  • European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy, 2022, Journal of the European Academy of Dermatology and Venereology
  • European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations, 2022, Journal of the European Academy of Dermatology and Venereology
  • Pruritus as a Distinctive Feature of Type 2 Inflammation, 2021, Vaccines
  • Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities, 2020, Frontiers in Pharmacology
  • Cutaneous manifestations of SARS-CoV-2 infection: a clinical update, 2020, Journal of the European Academy of Dermatology and Venereology

Their research collaborations have involved several frequent coauthors, including:

  • Paolo Gisondi
  • Francesco Bellinato
  • Martina Maurelli
  • Andrea Chiricozzi
  • Giuseppe Argenziano

Best Publications

  • Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I.

    A Wollenberg;S Barbarot;T Bieber;S Christen-Zaech

  • Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study

    Paolo Gisondi;Gianpaolo Tessari;A Conti;S Piaserico

  • European S3-guidelines on the systemic treatment of psoriasis vulgaris

    D Pathirana;AD Ormerod;P Saiag;Catherine Smith

  • Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions

    Batya B. Davidovici;Naveed Sattar;Prinz C. Jörg;Luis Puig

  • Epidemiology of atopic dermatitis in adults: Results from an international survey.

    S. Barbarot;S. Auziere;A. Gadkari;G. Girolomoni

  • Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey

    Mark G. Lebwohl;Hervé Bachelez;Jonathan Barker;Giampiero Girolomoni

  • IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.

    Cristina Albanesi;Andrea Cavani;Giampiero Girolomoni

  • Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2).

    C Paul;J Cather;M Gooderham;Y Poulin

  • European Consensus Statement on Phenotypes of Pustular Psoriasis

    A.A. Navarini;D. Burden;Francesca Capon;U. Mrowietz

  • Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment.

    Cristina Albanesi;Claudia Scarponi;Sabatino Pallotta;Roberta Daniele;Roberta Daniele

  • Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell–derived cytokines

    Maria Laura Giustizieri;Francesca Mascia;Alessandra Frezzolini;Ornella De Pità

  • Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes.

    Cristina Albanesi;Claudia Scarponi;Andrea Cavani;Monica Federici

  • Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial.

    Paolo Gisondi;Micol Del Giglio;Vincenzo Di Francesco;Mauro Zamboni

  • Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo.

    Marisa Vulcano;Cristina Albanesi;Antonella Stoppacciaro;Renzo Bagnati

  • The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis

    Cristina Albanesi;Stefania Madonna;Paolo Gisondi;Giampiero Girolomoni

  • Ultrasound imaging for the rheumatologist.

    S Beissert;I Cavazzana;F Mascia;P Meroni

  • Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment

    A Wollenberg;S Reitamo;F Atzori;M Lahfa

  • CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation.

    Chiara Ottaviani;Francesca Nasorri;Chiara Bedini;Ornella de Pità

  • Chemokine Receptor Expression and Function in CD4+ T Lymphocytes with Regulatory Activity

    Silvia Sebastiani;Paola Allavena;Cristina Albanesi;Francesca Nasorri

  • Psoriasis and the metabolic syndrome

    Paolo Gisondi;Anna Chiara Fostini;Irene Fossà;Giampiero Girolomoni

Frequent Co-Authors

Saveria Pastore
Saveria Pastore Istituto Dermopatico dell'Immacolata
Luigi Naldi
Luigi Naldi Centro Studi GISED
Giovanna Zambruno
Giovanna Zambruno Bambino Gesù Children's Hospital
Carle Paul
Carle Paul Federal University of Toulouse Midi-Pyrénées
Giovanni Pellacani
Giovanni Pellacani Sapienza University of Rome
Paola Ricciardi-Castagnoli
Paola Ricciardi-Castagnoli Toscana Life Sciences Foundation
Jo Lambert
Jo Lambert Ghent University Hospital
Johannes Norgauer
Johannes Norgauer Friedrich Schiller University Jena
Giuseppe Argenziano
Giuseppe Argenziano University of Campania "Luigi Vanvitelli"
Marco Idzko
Marco Idzko Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine offers many career options beyond becoming an MD. For those who want to start working quickly, 6 month lpn program paths provide a fast track into nursing, letting students enter the healthcare workforce sooner.

Nurses who already hold a BSN can advance their careers through specialized online programs. For example, bsn to np programs online allow registered nurses to become nurse practitioners and gain expertise in fields like psychiatric or family medicine.

For those interested in the business side of healthcare, a bachelors in healthcare administration offers a foundation in management, policy, and operations. This can lead to leadership roles in hospitals, clinics, or public health organizations.

Ambitious professionals can further their impact—and earning potential—with the cheapest master's in healthcare administration programs. These affordable, flexible degrees prepare graduates for high-level administrative and executive positions in the healthcare sector.

Best Scientists Citing Giampiero Girolomoni

Trending Scientists